We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Staining Method for Electron Microscope Specimens Safer and Cost-Effective

By LabMedica International staff writers
Posted on 06 Jun 2022

The electron microscopic staining technique for biological specimens using uranyl acetate (UA) was first reported in 1958 and has been used in electron microscopy facilities worldwide because of its simplicity and optimal staining results. More...

In recent years, however, international regulations on the use, acquisition, storage, and disposal of uranium compounds have become increasingly strict because uranium is used as a nuclear material for weapons. Against this backdrop, alternative staining methods have long been long awaited in the field of biological research, and several have been proposed, but none has been an effective alternative. In this context, alternative staining methods have long been expected in the bio-medical electron microscopic research field, and several have been proposed, though none has been an effective alternative. Now, researchers have developed a new staining method for electron microscope specimens based on double staining with hematoxylin, which is widely used as a staining agent for light microscopy, and lead solution. The new method is expected to replace the conventional method of double staining with uranium acetate and lead solution and is a better choice in terms of safety, cost, and ease of handling.

To develop a safe and easy-to-handle alternative staining method to UA for ultrathin sectioning in electron microscopy, researchers at Tokyo University of Technology (Tokyo, Japan) examined various commercially available dyes for light microscopy. The researchers found that double staining with Mayer's hematoxylin (MH), which is commonly used as a staining agent in light microscopy, and lead solution (Pb), exhibited staining properties equivalent to those of conventional electron microscopic double staining with UA and Pb in various tissues and cells.

Other cell organelles, such as nuclear chromatin, plasma membrane structures, ribosomes, glycogen, lipid droplets, cell adhesion apparatus, and cytoskeletal system(s), were stained with high contrast using the MH staining method. Plasma membrane staining in all samples was also satisfactory. Backscattered electron images of 200 nm semi-thin sections of mouse kidney observed by a field emission scanning electron microscope also showed that the MH and Pb staining techniques provided a wide-area and high-quality image of the renal cortical tubules and the renal glomerulus.

MH is a dye solution widely used for staining paraffin sections of diagnostic clinical specimens, and has the advantages of low cost, stable supply as a commercial product, and high safety of waste solution. On the other hand, the International Atomic Energy Agency's "International Basic Safety Standards for Protection against Ionizing Radiation and for the Safety of Radiation Sources" (BSS) has established specific exemption levels, and new regulations for radioactive materials are being developed internationally through legislation. Based on the results of this study, double staining with MH and Pb is expected to become a useful alternative to the staining method using radioactive UA in terms of reagent purchase, handling, use, storage, and liquid waste treatment.

Related Links:
Tokyo University of Technology 


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Serological Pipet Controller
PIPETBOY GENIUS
New
Enterovirus Test
Quanty Enterovirus System
New
cDNA Synthesis Kit
Ultimate cDNA Synthesis Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Ear wax could be a possible screening medium for Parkinson’s disease (Photo courtesy of 123RF)

Earwax Test Accurately Detects Parkinson’s by Identifying Odor Molecules

Current tests for Parkinson’s disease (PD) rely heavily on clinical scales and neuroimaging, which are often subjective, expensive, and ill-suited for routine screening. Since most treatments only slow... Read more

Molecular Diagnostics

view channel
Image: A family of molecules could help diagnose and treat breast cancer (Photo courtesy of Shutterstock)

Molecular Biomarkers Pave Way for New Tests to Diagnose and Predict Breast Cancer

Despite playing essential roles in tissue development and immune protection, the contribution of proteoglycans in cancer remains poorly understood. Some proteoglycans appear to shield the body from cancer,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: T cell immunity could be a marker for early Parkinson’s treatment (Photo courtesy of Shutterstock)

T Cells in Blood Can Detect Parkinson's Years Before Diagnosis

Diagnosing Parkinson’s disease before the appearance of motor symptoms remains one of neurology’s most significant challenges. Patients can go years—even decades—without a diagnosis, as subtle early indicators... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.